Alnylam Pharmaceuticals, Inc.
DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES
Last updated:
Abstract:
Methods, kits and devices for dosing a subject to reduce a hypersensitivy response to a lipid-formulated nucleic acid (e.g., RNA) molecule are disclosed.
Status:
Application
Type:
Utility
Filling date:
8 Apr 2021
Issue date:
16 Dec 2021